
doi: 10.3233/jpd-189004
pmid: 30741694
Adult, Aged, 80 and over, Clinical Trials as Topic, Adolescent, Parkinson Disease, Middle Aged, Young Adult, Clinical Trial Protocols as Topic, alpha-Synuclein, Humans, Immunotherapy, Aged
Adult, Aged, 80 and over, Clinical Trials as Topic, Adolescent, Parkinson Disease, Middle Aged, Young Adult, Clinical Trial Protocols as Topic, alpha-Synuclein, Humans, Immunotherapy, Aged
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 24 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
